Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-60
SponsorMing-an Yu

About this trial

The goal of this clinical trial is to test whether human-centered nursing care lowers emotional distress and improves quality of life for people who are awake during thyroid thermal ablation. The procedure uses local anesthesia, so participants remain awake and may feel tense. Human-centered care focuses on emotional support, clear communication, comfort, and follow-up, and it may improve the experience and recovery for patients.

The main questions are:

Does human-centered nursing care reduce emotional distress levels in patients undergoing thyroid thermal ablation?

Does human-centered nursing care improve patient quality of life after thyroid thermal ablation?

If there is a comparison group: Researchers will compare human-centered nursing care to usual nursing care to see if human-centered care leads to lower emotional distress and higher quality of life.

Participants will:

Receive either human-centered nursing care or usual nursing care.

Complete questionnaires before, during, and after the procedure to measure emotional distress, quality of life, pain, and satisfaction with care.

Have their vital signs and quality of life tracked during and after the procedure.

Have their adherence to care plans and any complications monitored.

The main outcomes are emotional distress levels and quality of life. Other outcomes include pain and vital signs during the procedure, satisfaction with care, and complication rates. Results may guide better care for people undergoing small, minimally invasive treatments while awake.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 16-60 years; scheduled for thyroid thermal ablation

Papillary thyroid carcinoma (PTC)

Number of target lesions <= 3

Largest lesion diameter <= 2 cm; clinical stage T1N0M0 by imaging

Disqualifiers

Serious medical comorbidities or cognitive impairment that precludes participation

Prior thyroid surgery or thermal ablation

Unwilling or unable to join the WeChat group or complete postoperative follow-up

Trial design

Design model

Parallel

Treatments tested in this trial

  • Humanistic Continuing Care via WeChat

    Behavioral

    Description: Structured, humanistic peri-operative nursing program delivered through WeChat in addition to routine care. Components: pre-procedure needs assessment and expectation setting; brief coping skills coaching (e.g., paced breathing); intra-procedure step-by-step explanations, reassurance, and comfort measures; post-procedure education, recovery guidance, and psychosocial support; symptom monitoring with red-flag escalation; medication/wound-care and appointment reminders; on-demand messaging during service hours; optional caregiver engagement. Delivery \& Schedule: Nurse-led. One pre-procedure session; intra-procedure support on the day of ablation; post-procedure WeChat check-ins at least weekly plus on-demand messaging for 12 weeks. Fidelity tracked via standardized checklists. Arm(s): Experimental - Humanistic Continuing Care via WeChat.

  • Usual Care (No Structured WeChat Program)

    Procedure/Surgery

    Participants receive standard peri-operative nursing and institutional discharge materials, including routine pre-procedure counseling, standard intra-procedure monitoring, printed/posted instructions for home care, and follow-up per usual practice (e.g., clinic visit or routine phone call). They may contact the clinic using standard channels as needed, but there is no scheduled, structured WeChat outreach or humanistic continuing-care protocol.

Treatment groups

108 Participants
are divided into 2 treatment groups
Group A: Humanistic Continuing Care via WeChatExperimental treatment 1 intervention
Group B: Usual Care (No Structured WeChat Program)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in emotion distress from baseline to post-procedure (HADS)

Time frame
From enrollment to the end of treatment at 3 months
2

Change in the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 scores from baseline to 3 months

Time frame
From enrollment to the end of treatment at 3 months
3

Change in Thyroid Cancer-Specific Quality of Life Questionnaire scores from baseline to 3 months

Time frame
From enrollment to 3 months after end of treatment

Secondary outcomes

1

Intraoperative pain intensity (Visual Analog Scale)

Pain intensity during the procedure will be assessed using a Visual Analog Scale (VAS; 0-100 mm, where 0 indicates no pain and 10 indicates the worst imaginable pain). A single VAS score will be recorded during the intraoperative period.

Time frame
Intraoperative period (during the procedure)
2

Patient satisfaction with nursing care (Newcastle Satisfaction with Nursing Scale, NSNS)

Time frame
Postoperative Day 1

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Ming-an Yu

Lead sponsor

China-Japan Friendship Hospital

Sponsor institution